Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
.png)
US Stock Market Move | BlackRock, Inc. (BLK.US) rose more than 4% with overall first quarter performance exceeding expectations.

US Stock Market Move | Large technology stocks surged, with Meta Platforms (META.US) rising more than 3%.

US Stock Market Move | Oil stocks fell, Occidental Petroleum Corporation (OXY.US) dropped more than 4%
US Stock Market Move | BlackRock, Inc. (BLK.US) rose more than 4% with overall first quarter performance exceeding expectations.
.png)
US Stock Market Move | Large technology stocks surged, with Meta Platforms (META.US) rising more than 3%.

US Stock Market Move | Oil stocks fell, Occidental Petroleum Corporation (OXY.US) dropped more than 4%

RECOMMEND

CICC: Why Have Earnings Trajectories Diverged Across US, A‑Share, And Hong Kong Markets?
14/04/2026

HKEX Introduces Two Cross‑Market Hard Technology Indices; Five Mainland Fund Subsidiaries In Hong Kong Receive First ETF Authorizations
14/04/2026

Consecutive Success As Rocket Achieves “One Rocket, Eight Satellites,” China’s Commercial Spaceflight Enters The Dedicated‑Ride Era
14/04/2026


